This map shows the geographic impact of Pfeffer Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pfeffer Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pfeffer Ma more than expected).
This network shows the impact of papers produced by Pfeffer Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pfeffer Ma. The network helps show where Pfeffer Ma may publish in the future.
Co-authorship network of co-authors of Pfeffer Ma
This figure shows the co-authorship network connecting the top 25 collaborators of Pfeffer Ma.
A scholar is included among the top collaborators of Pfeffer Ma based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Pfeffer Ma. Pfeffer Ma is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
19 of 19 papers shown
1.
Amigoni, Maria, Deepa Mangalat, Mikhail Bourgoun, et al.. (2005). Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: Prognostic significance and relation to ventricular size and function. Journal of the American College of Cardiology. 45(3).1 indexed citations
2.
McMurray, John J.V., et al.. (2005). Chronic renal disease and cardiovascular risk - Reply.1 indexed citations
3.
Kenchaiah, Satish, Karl Swedberg, HD White, et al.. (2004). Modifiable Risk Factors for Stroke in High-Risk Patients following Acute Myocardial Infarction: Insights from the VALIANT Study. Circulation. 110(17).
Køber, Lars, Pfeffer Ma, C. Torp‐Pedersen, et al.. (1997). Meta-analysis of individual patient data from trials of long-term ACE-inhibitor treatment after acute myocardial infarction (SAVE, AIRE, and TRACE studies). Circulation. 96(8). 3951–3951.5 indexed citations
8.
Ma, Pfeffer, et al.. (1994). Prevention of post-infarction left ventricular remodeling by ACE-inhibitors.. PubMed. 39(12 Suppl 1). 27–30.3 indexed citations
9.
Ma, Pfeffer, et al.. (1994). Ventricular remodeling after myocardial infarction: a modifiable process.. PubMed. 3(3). 164–8.2 indexed citations
10.
Ma, Pfeffer. (1994). Left ventricular remodeling following myocardial infarction.. PubMed. 39(12 Suppl 1). 25–6.4 indexed citations
11.
Ma, Pfeffer, et al.. (1993). [Effect of captopril on mortality and morbidity in patients with dysfunction of the left ventricle after myocardial infarction. Results on survival and hypertrophic studies].. PubMed. 33(12). 14–23, 3.2 indexed citations
12.
Ma, Pfeffer. (1991). Angiotensin converting enzyme inhibition therapy following myocardial infarction. Rationale for clinical trials.. PubMed. 16 Spec No 1. 278–82.3 indexed citations
13.
Ma, Pfeffer, et al.. (1987). Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure.. PubMed. 75(1 Pt 2). I149–55.92 indexed citations
14.
Ichikawa, Iekuni, et al.. (1987). Role of angiotensin II in the altered renal function of heart failure.. PubMed. 20. S213–5.2 indexed citations
15.
Ma, Pfeffer, et al.. (1983). Blood pressure and left ventricular dysfunction in the spontaneously hypertensive rat.. PubMed. 42(10). 2698–702.3 indexed citations
16.
Spadaro, J, et al.. (1980). Characterization of myocardial infarcts in the rat.. PubMed. 104(4). 179–83.59 indexed citations
17.
Ma, Pfeffer, et al.. (1977). Development of a hypertensive strain of Wistar rats from previously normotensive but labile normals.. PubMed. 89(6). 1163–7.2 indexed citations
18.
Ma, Pfeffer & Frohlich Ed. (1973). Hemodynamic and myocardial function in young and old normotensive and spontaneously hypertensive rats.. PubMed. 32. Suppl 1:28–38.114 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.